chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves patient (unknown demography) who got flu (influenza), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
pt recv vax & 1 day later exp a 5x5 cm indurated, warm, & red patch @ inj site;2 days post vax the patch was 12x13cm;pt treated w/DPh elixir & cool compress;pt will be seen by MD;sx persisted as of 14NOV96;
Vaccine was given to 16 year old; A spontaneous report was received from a pharmacist  concerning a 16-year-old, female patient who experienced: Vaccine was given to 16-year-old.    The patient's medical history was not provided.  Concomitant product use was not provided/unknown by the reporter.     On 17FEB2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 023M20A) intramuscularly for prophylaxis of COVID-19 infection.   Director of pharmacy reported that the first dose of the vaccine was given to a 16 year old patient and wanted to see if they could register for clinical trials.   Treatment information was not provided/unknown.    Action taken with mRNA-1273 in response to the event  was unknown.  The event, vaccine was given to 16-year-old was considered recovered/resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-014927:different patient, same reporter
Itchiness began to occur 4 days after at injection site. Itchiness became increasingly intense. The area around the injection site around day 5-6 became hard and disc-shaped with redness within a 2 1/2" radius around injection site.  The area became raised on day 6 for 5 more days. Day 13, the itching, raised and most of the redness has subsided. I have noticed, though, that the redness has become oval shaped rather that circular in line with the muscle.
Patient recieved #2 of #3 HPV vaccine and within 3 minutes, had a vasovagal reaction.  She lost conciousness and was lowered to the floor. Patient became conscious about 30 seconds later and was having difficulty responding.  Her legs were elevated and a cold pack was applied to her forehead. Her blood pressure was low and the Provider felt that she needed IV fluids and was transferred to the Emergency Department.  She was discharged the same day in satisfactory condition.
Hive like rash across abdomen with urticaria started 24 hour after Hepatitis B vaccine administration. Self treated with BENADRYL OTC and topical hydrocortisone cream otc. Rash resolving.
Urticaria upper arms, legs, back and abdomen 2 hours after immunization. Pruritic rash. Treated with Sarna lotion 190 hydrocortisone topical and atarax 25 mg 1/2 tablet PO q 6 hours PRN.
I had fatigue, fever, loss of taste and smell. I also have congestive, brain fog and a cough. These lasted for about a week, but the cough lasted about a month and the brain fog lasted for about 2 months. On Dec 24th, I tested positive for COVID-19. And now I have been diagnosed with an autoimmune disease. I have had blood work done, that confirmed the autoimmune disease.
No reactions. Pharmacist called patient right away when realized the shot expired in 1.17.
Mild Vertigo/dizziness tilting head back or standing up quickly.  Started 3 days after 2nd shot.  Continues through today
Pain; hard lump; continued tenderness to touch w/radiating pain-lump and tender to touch/radiating pain continued 1 mo. No real treatment done at this time. Seen for evaluation today.
Headaches ongoing every day since, went to PCP, as of 08.09.21 still ongoing. Heart Palpitations - every day. Went to cardiologist. Changes in vision in right eye - blurry vision and purple haze - went to Ophthalmologist. Sinus infection went to urgent care on 7/14/21. Root Canal on 7/26/21. Dizziness started 08.01.21 and Vertigo started on 08.02.21. Returned to PCP. Went to physical therapy on 08.09.21. Anxiety/depression - went to therapist on 07.29.21. COVID recovery program started on 08.06.21.
Patient reports hives all over her body about 12 days after second dose of Pfizer COVID vaccine. Patient states provider gave prescriptions for hydroxyzine and topical steroid which are helping and hives are improving.
Lyme's disease; Arm where she was vaccinated was sore; This is a spontaneous report from a non-contactable consumer from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on 26Feb2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date in 2021, the patient's doctor thought that the patient may have Lyme's disease and he would like to put her on antibiotics and probiotics and called to see if she can take them and still get an effective vaccine. The patient also mentioned that the arm where she was vaccinated was sore, on an unknown date in 2021. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained. No further information is expected.
Gestational age 30w6d EDD 3/31/22 Breakthrough COVID infection, admitted to hospital with severe abd pain, not in active labor
I had noticed a minimal pain in my pec, but then a pump or DOMS sensation, almost minimal grade strain, thought nothing of it, just "that's odd".  Then last night 3/10/2021 I felt a nerve time pain in my axillary space.  I know nerves can be "funny" at times since understanding pain science and low grade nerve information and still didn't think that was odd.  Today this morning 3/11/201 during my 545am work out I noticed around 6:15 am my delt (injection site) was very red.  Later it got itchy, and now 8:14pm swollen and starting to get warm, and the redness ring is now twice the size of my morning work out.  Pain is minimal none, just minor sorness (a 1/4th of the after day sorness from shot).  My pec area feels off.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On 29-AUG-2017, the patient was vaccinated with an improperly stored dose of VARIVAX, lot # M037643 with expiry date 01-SEP-2018 (dose, route and frequency were not reported) reconstituted with properly stored sterile diluent (MRK INJ) for prophylaxis. No adverse effects reported. The administered dose experienced a temperature excursion of 6 degree Fahrenheit to 14 degree Fahrenheit for a time frame of 1 hour 9 minutes. There was no previous temperature excursions. The call was because of data logger. There was no Product Quality Complaint (PQC) involved.
Information regarding Prevnar was received from a consumer regarding a 13-month-old male patient who was inadvertently given a fifth dose of Prevnar and developed a fever. At 13 months of age, the patient received the fifth dose on 03-Apr-2006. The patient also received a dose of Varicella Virus Vaccine, live (manufacturer unknown) and M-M-R (Merck Sharp & Dome) on 03-Apr-2006. Indication for Prevnar was immunization. Product was administered on 03-Apr-2006. Dose regimen was 1 dose 1 time per day (intramuscular). Concomitant medications were not reported. A father reported that his son was inadvertently given a fifth dose of Prevnar (incorrect dose administered) (accidental overdose) on 03-Apr-2006. At this time, the patient also received a dose of Varicella Virus Vaccine, Live and M-M-R ; on 01-Mar-2006, the child had previously received these vaccines along with a 4th dose of Prevnar. On 04-Apr-2006 the patient developed a fever (pyrexia). On an unspecified date, the fever resolved. The family reportedly stated that the patient "still isn't the same" No additional information was available at the time of this report.
COVID-19 Vaccine, MRNA, (Pfizer) Mcg/0.3 Ml IM Susp (purple) use for COVID-19 under Emergency Use Authorization (EUA): Pfizer Covid Vaccine was prepared at 10:42 and delivered around 11:00 to 5W. It was unknown to who delivered this medication. I spoke with the pharmacist, all employees in bullpen at the time and all deny delivering this med. A yellow sheet was prepared to document delivery, but this yellow sheet was not returned to pharmacy to show who delivered it. The syringe was dispensed in a brown light protect bag. After 15:00, RN messaged for medication saying that the syringe they had was completely depressed and not medication was in syringe. Medication would have been expired by this time as these doses need to be used within an hour of drawing up. We prepared a new dose and technician retrieved old dose. The old dose had been completely depressed and dose expelled into syringe cap. Additionally, syringe had been repackaged from it's light protect bag into a refrigerator bag and placed back in pyxis. We are not sure who depressed the plunger or repackaged the syringe into a different bag. All employees deny delivering this medication. I asked if anyone placed this syringe in the stat bin on operations side to be delivered and they denied this as well. We attempted to call orange AM tech to see if it wan accidentally placed on delivery, but we were not able to reach them. Overall this was very bizarre situation and we're not sure what happened to the yellow delivery sheet which would offer some clarity.
Patient reported injection site is still red, swollen, hot and itching 3 days after injection
Early period?I don?t have a period and got one despite not taking meds.   Canker sores?started one month ago, never got cancer sores in my life but now getting them.   Muscle spasms in left middle finger. Started a week ago, hasn?t stopped.
Pt recvd Hep B vax & exp a low grade fever, myalgias, stiffness & pain w/activity in the injected arm; pt was seen by MD who noted tenderness over the muscles of upper & lower extremities;
Redness, swelling, swollen area on left arm is hard, injection site is very warm to touch and left arm hurts to move.
how high will my fever get/ if it was normal and how high on average; This case was reported by a consumer via call center representative and described the occurrence of fever in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   The reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. At the time of reporting, the patient had fever due to shingles shot. The patient was wondering how high his/her fever would get, on average with the first dose. The patient wanted to know if it was normal and how high on average it usually gets for people. The follow-up would not possible as no contact details were available.
Pt reported on 01/08/19 (approx. 27 days post vaccination) fever of 101.3, vaccine site redness, hot to touch, swelling and pain radiating to left axillary/shoulder. Pt denies chest pain or breathing difficulty. Pt informed she had no vaccine complications prior to 01/08/19. Pt denies prior vaccine reactions.
On January 26th I woke up  with hives. My entire body was red and through the day the hives spread more and towards my face. My body was very hot no temperature. I took 2 doses of Benadryl.  First dose  I took in the morning and second dose after 5 hours. The hives started getting worst by 5:30 pm.  I called the on call nurse service and then after speaking with the nurse, I went to the urgent care here in .   I was prescribed prednisole started at 40 ml, Benadryl as needed, and Zyrtec also as needed.  Trough the 10 days I had the following symptoms: Excruciating headaches, itching, strong shivers, and electrical like cramps through the day. I had no appetite and the shivers were very debilitating.
Sunday 3/21 (2 days after vaccine): itchy rash on entire neck, shoulder, ears and left abdomen - took Claritin and used hydro cortisol cream and the rash subsided.  Monday 3/22: mid way through work shift, felt extremely dizzy, jittery and light headed. Difficult to stand and walk on my own and rash started to come back. Went to care.
the injection site was red and warm to the touch; injection site was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (the injection site was red and warm to the touch) and VACCINATION SITE ERYTHEMA (injection site was red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, the patient experienced VACCINATION SITE WARMTH (the injection site was red and warm to the touch) and VACCINATION SITE ERYTHEMA (injection site was red). At the time of the report, VACCINATION SITE WARMTH (the injection site was red and warm to the touch) and VACCINATION SITE ERYTHEMA (injection site was red) had not resolved.            No concomitant medication was reported.                   No treatment medication was reported.
about 7 min after injection started with palpitations, throat sensations , tightness in chest , anxiety, pale skin. mild elevation of blood pression and tachycardia to 100. exam done: stable vital signs with normal oxygenation clear airway (speaking and awake and alert) given water and encouraged slow even breaths. after 1.5-2 min started feeling better, given snack. and over the next 5 min resolved. no medicines required. panic/anxiety attack without other provocation
Shortness of breath; Nerve pain; Stomach upset; Sweating; Chills; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNOEA (Shortness of breath), NEURALGIA (Nerve pain), ABDOMINAL DISCOMFORT (Stomach upset), HYPERHIDROSIS (Sweating) and CHILLS (Chills) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CITALOPRAM and BUSPIRONE for an unknown indication.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Other) 1 dosage form. On 01-May-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset), HYPERHIDROSIS (Sweating), CHILLS (Chills) and FATIGUE (Fatigue). On 02-May-2021, the patient experienced NEURALGIA (Nerve pain). On 13-May-2021, the patient experienced DYSPNOEA (Shortness of breath). The patient was treated with PARACETAMOL (TYLENOL) for Fatigue, at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Shortness of breath), NEURALGIA (Nerve pain), ABDOMINAL DISCOMFORT (Stomach upset), HYPERHIDROSIS (Sweating), CHILLS (Chills) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Other) was unknown.       Treatment medication also included nausea pill.
It started around 07/05/2021 it was a dry cough, body aches, nasal congestion, and headaches. I did not have a fever. It was below 100. It started out like a cold but then I felt a lot worse. The people I were with got sick so I thought I picked up the same thing. I got tested for Covid 07/07/2021 because some of the other people were positive. Mine came back negative. Then, I went to the doctor on 07/09/2021 at urgent care. They checked me out and listened to my lungs. They said it was bronchitis so they put me on Doxycycline and Zyrtec. They did not give me any steroids but they told me to take Mucinex twice a day and some cough syrup as needed. I also took some Tylenol. It was a 10 day course of Doxycycline. When I went back to my doctor on 07/19/2021 for a regular physical, she listened to my lungs and she said I did not need any further medications.
Patient reports similar rash to first vaccine but less severe. He came to urgent care for rash that developed the day after receiving the 2nd Moderna Vaccine- rash is erythematic, painful, and blistered. He was treated for allergic reaction and was prescribed prednisone and hydroxyzine. He was instructed to go to Emergency Room if rash worsens or other symptoms develop.
Approximately 7.5c.m wide and 10 c.m long Erythema noted 1.5 cm below the site of Flu vaccine given. Site is redness and warm to touch.
This spontaneous report as received from a pharmacist refers to a currently 67 year old female patient. No information regarding the patient's medical history or concurrent conditions was provided. On an unspecified date, the patient was vaccinated intramuscularly (instead of subcutaneously) with a dose of ZOSTAVAX injection (dose, lot# and expiry date were not reported). There were no concomitant therapies reported. On an unknown date, the patient had an unspecified "terrible reaction" to ZOSTAVAX. The reporter could not describe the reaction other than that it lasted a few days. The outcome of the event was not reported. The relatedness between ZOSTAVAX and the event was not provided. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of macular rash in a 69-year-old female patient who received SHINGRIX (batch number G72ZD, expiry date 24th November 2020) for prophylaxis. On 21st February 2019, the patient received SHINGRIX. In February 2019, less than a week after receiving SHINGRIX, the patient experienced macular rash, injection site pain and injection site itching. On 21st February 2019, the patient experienced pain in arm. On an unknown date, the outcome of the macular rash was not recovered/not resolved and the outcome of the injection site pain and injection site itching were unknown and the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the macular rash, injection site pain, injection site itching and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The case was reported by patient's husband. The patient received vaccine on left arm. After receiving SHINGRIX, the patient experienced a sharp pain that went down her arm for a very short time for less than a couple of minutes. The patient also experienced soreness at the injection site and itching. It was reported that GSK could follow up if necessary.
Pt came in with persistent nausea, vomiting, and diarrhea.  She has a past medical history of chronic diastolic heart failure, diabetes, and pulmonary hypertension.  Pt was found to be COVID positive.
Information has been received from a physician concerning a 15 year old female patient with Opitz syndrome (hypertelorism-hypospadias), Turner's syndrome and migraines who was on 12-MAR-2007 vaccinated with a first dose of Gardasil, lot #654389/0961F (dose not reported). Concomitant therapy included TOPAMAX, fentanyl and other "unknown medications". On 19-MAR-2007 the patient developed a movement disorder characterized by "verbal and bodily" tics. On 20-MAR-2007 patient was hospitalized and treated with IV fluids. Unspecified laboratory tests were normal. She was seen by a neurologist who felt her tics were volitional because she could stop them when asked. Another neurologist felt the tics were not volitional because they occurred in her sleep. At the time of this report, the patient had not recovered. The physician considered the events to be disabling since she was unable to feed herself. Additional information has been requested.
Extremely tired headache runny nose, sniffles body ache very nauseas today  vomiting
He has not had any adverse events. He was given 10 doses. (1 complete vial that was not diluted)
This spontaneous report as received from a nurse refers to a unspecified number of patients of unknown age. The patients medical history was not reported. On an unknown date the patient was vaccinated with ZOSTAVAX exposed to 24 Fahrenheit (F) for 3.5 hours. The outcome of unspecified patients received ZOSTAVAX  exposed to maximum of 24 F for 3.5 hours was unknown. This case was linked to case # 1404USA015711 (Same reporter link). Additional information has been requested.
I'm not sure about anatomy and where or if there are lymph nodes in the head; lump behind her left ear which was measured to be 1 inch in length and a 1/2 inch in width and another lump on her head under her hair so it was difficult to visualize; had issues swallowing; her gums were swollen; Potentially a lymph node that got inflamed; This is a spontaneous report from a contactable Pharmacist via Medical Information Team.  A 29-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number: ew0191 and expiration date: sep2021) via intramuscular route of administration at left deltoid on 05Jun2021 14:30 (at the age of 29-year-old) as dose 1 single for COVID-19 immunisation. Patient medical history and Concomitant medications were not reported. On an unspecified date patient experienced a lump behind her left ear which was measured to be 1 inch in length and a 1/2 inch in width and another lump on her head under her hair, so it was difficult to visualize. The caller reports that initially when the lump showed up it was not bothering her but now the patient sates that it was. initially after receiving the vaccine, had issues swallowing and her gums were swollen and Potentially a lymph node that got inflamed and patient was not sure about anatomy and where or if there are lymph nodes in the head. Outcome of the events was had issues swallowing and her gums were swollen was recovered on an unknown date and rest all the events were not recovered.   Information on Lot/Batch number has been requested.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect vaccine BNT162B2 in triggering the onset of lymphoma cannot be excluded . The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Employee comes in 10-17-07 @ 1630-says her arm very sore, red and puffy. 30cm x 15 cm red raised bump at injection site; then 135 cm x 100 cm red "hive" below inj site. 10-19-07 called empl. says no longer red, just tender to touch. 10-24-07 pain gone now. Resolved